03 May 2019
: Case report
Cardiac Arrest Due to Benzonatate Overdose
Unknown etiology, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Patient complains / malpractice, Adverse events of drug therapy , Educational Purpose (only if useful for a systematic review or synthesis)
Chongfei Jin1BCDEF*, Erum Zahid2CDE, Andleed Sherazi1BC, Mujibur R. Majumder2FG, Puneet Bedi3DEDOI: 10.12659/AJCR.915151
Am J Case Rep 2019; 20:640-642
Abstract
BACKGROUND: Benzonatate is one of the most widely prescribed nonnarcotic antitussives to relieve cough symptoms. As a structurally similar agent to other local anesthetics, including tetracaine and procaine, the risk to the public is not fully appreciated.
CASE REPORT: A 37-year-old female presented to the Emergency Department (ED) status post cardiac arrest. Advanced cardiac life support (ACLS) protocol was performed, and return of spontaneous circulation (ROSC) was achieved. Total downtime was 30 minutes. The patient was intubated, sedated, and hypothermia protocol was initiated. The patient developed bradyarrhythmia and mild coagulopathy suspicious for disseminated intravascular coagulation (DIC), thus hypothermia protocol was terminated later. A review of laboratory data showed acidosis with pH of 6.87, mixed acidosis secondary to high anion gap metabolic and respiratory acidosis with elevated liver enzymes. It was reported that approximately 2 hours prior to her presentation; the patient had ingested less than 30 pills of benzonatate 200 mg capsules with alcohol.
CONCLUSIONS: Ingestion of benzonatate, a widely prescribed antitussive, may pose a risk to patients due to the potential for rapid development of life-threatening adverse events and limited treatment options in the overdose setting, not only in children but also in adults. Rational prescribing and patient education are needed.
Keywords: Acidosis, Antitussive Agents, Death, Sudden, Cardiac, Butylamines, Drug Overdose, Heart Arrest
1604 26
In Press
09 Jun 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.939250
08 Jun 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.939098
06 Jun 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.940200
05 Jun 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.939421
Most Viewed Current Articles
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
13 Jul 2022 : Case report
DOI :10.12659/AJCR.936441
Am J Case Rep 2022; 23:e936441
07 Dec 2021 : Case report
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250